149 related articles for article (PubMed ID: 36249621)
21. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
[TBL] [Abstract][Full Text] [Related]
22. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
Vasconcelos I; Wiesske A; Schoenegg W
Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
[TBL] [Abstract][Full Text] [Related]
23. The Role of Hair Loss in Cancer Identity: Perceptions of Chemotherapy-Induced Alopecia Among Women Treated for Early-Stage Breast Cancer or Ductal Carcinoma in Situ.
Trusson D; Pilnick A
Cancer Nurs; 2017; 40(2):E9-E16. PubMed ID: 27070222
[TBL] [Abstract][Full Text] [Related]
24. PRO Hair Safe Study: The Patient's Perspective on the Effects of Scalp Cooling on Hair Preservation.
Brunner C; Egle D; Ritter M; Kofler R; Giesinger JM; Schneitter L; Sztankay M; Emmelheinz M; Abdel Azim S; Wieser V; Oberguggenberger A
Breast Cancer (Dove Med Press); 2023; 15():485-494. PubMed ID: 37484698
[TBL] [Abstract][Full Text] [Related]
25. "Hair is your crown and glory" - Black women's experiences of living with alopecia and the role of social support.
Clarke-Jeffers P; Keyte R; Connabeer K
Health Psychol Rep; 2024; 12(2):154-165. PubMed ID: 38628276
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study.
Kinoshita T; Nakayama T; Fukuma E; Inokuchi M; Ishiguro H; Ogo E; Kikuchi M; Jinno H; Yamazaki N; Toi M
Front Oncol; 2019; 9():733. PubMed ID: 31448235
[No Abstract] [Full Text] [Related]
27. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
[TBL] [Abstract][Full Text] [Related]
28. Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Fujii T; Ichiba K; Honda C; Tokuda S; Nakazawa Y; Ogino M; Kurozumi S; Obayashi S; Yajima R; Shirabe K
Breast Cancer; 2021 Mar; 28(2):329-334. PubMed ID: 32944881
[TBL] [Abstract][Full Text] [Related]
29. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
[TBL] [Abstract][Full Text] [Related]
30. Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients.
Kraehenbuehl L; Kang D; Bang AS; Ketosugbo KF; Hay J; Patil S; Goldfarb S; Cho J; Lacouture ME
Support Care Cancer; 2024 May; 32(6):369. PubMed ID: 38773008
[TBL] [Abstract][Full Text] [Related]
31. 'My wig has been my journey's companion': perceived effects of an aesthetic care programme for Italian women suffering from chemotherapy-induced alopecia.
Zannini L; Verderame F; Cucchiara G; Zinna B; Alba A; Ferrara M
Eur J Cancer Care (Engl); 2012 Sep; 21(5):650-60. PubMed ID: 22339814
[TBL] [Abstract][Full Text] [Related]
32. Can you pull it off? Appearance modifying behaviours adopted by wig users with alopecia in social interactions.
Wiggins S; Moore-Millar K; Thomson A
Body Image; 2014 Mar; 11(2):156-66. PubMed ID: 24582351
[TBL] [Abstract][Full Text] [Related]
33. A mixed methods survey of social anxiety, anxiety, depression and wig use in alopecia.
Montgomery K; White C; Thompson A
BMJ Open; 2017 May; 7(4):e015468. PubMed ID: 28473521
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy-induced irreversible alopecia in early breast cancer patients.
Kim GM; Kim S; Park HS; Kim JY; Nam S; Park S; Kim SI; Kim D; Sohn J
Breast Cancer Res Treat; 2017 Jun; 163(3):527-533. PubMed ID: 28324267
[TBL] [Abstract][Full Text] [Related]
35. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors.
Bhoyrul B; Asfour L; Lutz G; Mitchell L; Jerjen R; Sinclair RD; Holmes S; Chaudhry IH; Harries MJ
JAMA Dermatol; 2021 Nov; 157(11):1335-1342. PubMed ID: 34586345
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of a computer-imaging program to prepare women for chemotherapy-related alopecia.
McGarvey EL; Leon-Verdin M; Baum LD; Bloomfield K; Brenin DR; Koopman C; Acton S; Clark B; Parker BE
Psychooncology; 2010 Jul; 19(7):756-66. PubMed ID: 19998333
[TBL] [Abstract][Full Text] [Related]
39. Psychosocial reaction patterns to alopecia in female patients with gynecological cancer undergoing chemotherapy.
Ishida K; Ishida J; Kiyoko K
Asian Pac J Cancer Prev; 2015; 16(3):1225-33. PubMed ID: 25735360
[TBL] [Abstract][Full Text] [Related]
40. Treatment of chemotherapy-induced alopecia.
Yeager CE; Olsen EA
Dermatol Ther; 2011; 24(4):432-42. PubMed ID: 21910801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
